Improving Medication Adherence in ADHD Adolescents



Status:Terminated
Conditions:Psychiatric, ADHD
Therapuetic Areas:Psychiatry / Psychology, Other
Healthy:No
Age Range:12 - 16
Updated:2/21/2018
Start Date:September 2015
End Date:June 2016

Use our guide to learn which trials are right for you!

Investigates whether a family-based intervention for adolescents with Attention Deficit
Hyperactivity Disorder (ADHD) will improve adherence to prescribed medication regimen in
adolescents with history of medication nonadherence.

We will evaluate a dual component family-based intervention for adolescents with ADHD to
improve medication adherence (Supporting Teen Adherence and Responsibility; STAR). STAR pairs
Motivational Interviewing with parent-teen behavioral contracting. In the proposed study,
adolescents with ADHD and a history of chronic nonadherence to their ADHD medication will be
randomly assigned to medication alone (medication as usual: MAU) or MAU+STAR. They will be
treated for 6 months with a 12 month maintenance period and 12 month followup. All
interventions will occur at the offices of participants primary care physicians.

Inclusion Criteria:

- Diagnosis of ADHD; currently prescribed an FDA-approved medication for ADHD, history
of medication nonadherence (taking less than 60% of prescribed doses); full scale
Intelligence Quotient >80, no current language delay and/or had no language delays
before age 3.

Exclusion Criteria:

- active medical conditions that could be worsened by stimulants (seizures, arrhythmias,
hypertension) unless patient has clearance from primary specialist taking care of
existing condition, pregnancy, Bipolar Disorder, schizophrenia, and/or other psychotic
disorders, and diagnosis of current substance abuse or dependence (except nicotine),
current psychotropic medication for conditions other than ADHD.
We found this trial at
1
site
Miami, Florida 33199
Principal Investigator: William E Pelham, Ph.D.
Phone: 305-348-0477
?
mi
from
Miami, FL
Click here to add this to my saved trials